Interferon-α Therapy Associated With the Development of Sarcoidosis
Open Access
- 1 August 1999
- Vol. 116 (2), 569-572
- https://doi.org/10.1378/chest.116.2.569
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- ETIOLOGY OF SARCOIDOSISClinics in Chest Medicine, 1997
- Side effects of high-dose interferon therapy for chronic hepatitis CJournal of Hepatology, 1996
- Interferon-?? in Malignant and Viral DiseasesDrugs, 1993
- Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapyCancer, 1990
- Pulmonary Sarcoidosis Following Interferon Therapy for Advanced Renal Cell CarcinomaCancer, 1987
- Role of Alveolar Macrophage‐ and Lung T Cell‐derived Mediators in Pulmonary SarcoidosisAnnals of the New York Academy of Sciences, 1986
- Clinical toxicity of interferons in cancer patients: a review.Journal of Clinical Oncology, 1986
- Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.JCI Insight, 1985
- Spontaneous Release of Interleukin-2 by Lung T Lymphocytes in Active Pulmonary SarcoidosisNew England Journal of Medicine, 1983
- T-lymphocyte subsets in peripheral blood and lung lavage in idiopathic pulmonary fibrosis and sarcoidosis: Analysis by monoclonal antibodies and flow cytometryClinical Immunology and Immunopathology, 1982